Last week, the pharmaceuticals giant Johnson & Johnson was ordered to pay just over $570m (€518m) in compensation by a court in the south western US state of Oklahoma. Irony of ironies, the company’s share price rose following the news, the markets having anticipated that the award would be even higher.

RESEARCHERS in Ireland’s third-level colleges are increasingly engaging with companies seeking to develop new products or boost their efficiency.

A Cork engineering and software firm has said it will create up to 180 new jobs after opening a new customer innovation centre.

Johnson & Johnson has agreed to pay about $1bn (€893m) to resolve most lawsuits claiming it sold defective metal-on-metal hips that had to be removed, according to people with knowledge of the matter.

Three months ago, Johnson & Johnson (J&J) predicted an ugly 2019 as the healthcare giant faced thousands of consumer lawsuits and pressure in the US on drug prices.

Bayer and Johnson & Johnson have agreed to settle more than 25,000 US lawsuits alleging that their blockbuster blood thinner Xarelto caused unstoppable and in some cases fatal bleeding, court documents showed.

Janssen Sciences UC, based in Ringaskiddy, and its sister site Janssen Pharmaceutical Sciences UC, based in Little Island, are part of the Johnson & Johnson family of companies, the world’s most comprehensive manufacturer of healthcare products as well as related services.

Girls have been inspired to take up science, tech, engineering and maths (STEM) subjects and consider careers in the sector thanks to the largest showcase of its kind in Ireland.

Shares in Johnson & Johnson, which employs 2,200 people at Irish sales facilities and plants, fell after the company reported disappointing pharmaceutical and consumer product sales.

The huge strengths of Ireland’s exporting base — which helped the country get through its worst ever economic crisis — were highlighted yesterday in the annual publication of the list of the top exporters on the island.

In one of the largest healthcare fraud settlements in US history, Johnson & Johnson will pay $2.2 billion (€1.6bn) to end civil and criminal investigations into kickbacks to pharmacists and the marketing of pharmaceuticals for off-label uses, US attorney general Eric Holder has said.

Three foreign suppliers of infant formula said today that China has fined them in a price-fixing investigation.

Johnson & Johnson, the world’s largest seller of healthcare products, won approval for the first in a new family of diabetes drugs, giving them the edge against rivals developing similar medicines.

Funding worth a total of €39m was announced today for 30 flagship scientific research projects which will support the work of over 150 researchers.

Johnson & Johnson may sell the global trauma business of its DePuy unit to Biomet Inc for $280m (€210m) in cash to remove a regulatory obstacle to its planned purchase of Synthes Inc.

ELAN has ceased the two highest doses in clinical trials of one of its main Alzheimer’s treatments following the deaths of nine people, even though those deaths have not been directly linked to the trial.

ELAN has updated its full-year guidance to allow for a forecast of adjusted earnings before interest, tax, depreciation and amortisation (EBITDA) of $75 million (€50m), after it reported a switch from net loss to net profit for its third quarter.

INTERNATIONAL healthcare giant Johnson & Johnson (J&J) formally became a significant shareholder in Irish pharmaceutical firm Elan yesterday as its amended equity investment deal was finally completed.

SHARES in Irish pharmaceutical firm Elan rose 20c, or nearly 4%, yesterday after it successfully fixed its Tysabri collaboration breach with Biogen Idec, by renegotiating its equity sale deal with Johnson & Johnson (J&J).

IRISH pharmaceutical firm Elan will have to restructure its €1 billion strategic development deal with US healthcare giant Johnson & Johnson (J&J) before the end of this month.

JOHNSON & Johnson has sued the American Red Cross over the use by the relief group and its partners of the company’s trademark red cross logo on first aid kits, hand sanitiser and medical gloves sold to the public.

JOHNSON & Johnson has announced plans to eliminate 3-4% of its global workforce of about 120,500 people as part of an effort to improve its cost structure.

THE world’s largest health care product manufacturer, The Johnson & Johnson (J&J) group, yesterday took its first steps towards sponsoring a number of customised courses in partnership with Cork Institute of Technology (CIT).

A US-STYLE project aimed at encouraging students in disadvantaged areas to stick with education was introduced in Ireland for the first time yesterday.

US stocks rose moderately for a second consecutive session today, boosted by strong earnings from United Technologies and McDonalds.

US stocks were little changed today as a slowdown in retail sales and profit warnings from Lucent Technologies and Tyco International Ltd. kept Wall Street investors from building on earlier gains. The major indexes finished the week flat.

US stocks resumed their advance on Wall Street today after New York’s Federal Reserve president said in a speech that US inflation was “quite moderate”.

JOHNSON & Johnson may abandon a $25.4 billion (€21.04bn) acquisition of Guidant Corporation because Guidant refused to accept revised terms after it recalled faulty heart defibrillators in June.

Stocks were narrowly mixed on Wall Street today, despite solid results from Johnson & Johnson and several banking companies.

US consumer products company Johnson & Johnson said first-quarter revenue jumped 18% to $11.6bn (€9.72bn), boosted by increased sales of pharmaceutical products and a 5.4% boost in revenue from foreign exchange rates.

Health care giant Johnson & Johnson has posted a 33 % increase in fourth-quarter profit , led by increased sales for its drugs, medical devices and health products.

US investors intent on collecting profits from Friday’s big gains looked past a series of positive earnings reports today and sent blue chip stocks moderately lower. The falling dollar and rising price of oil contributed to the selling.

Dow industrials component Johnson & Johnson has gained 35 cents to US$50.41.